8-K/A XBRL

8-K/A

Company: SANGAMO THERAPEUTICS, INC
Filed: June 18, 2020
Period of Report: June 18, 2020
Accession Number: 0001193125-20-172284

View Document ↗ View on SEC.gov ↗